The trademark application LINDONE was filed by EXELTIS HEALTHCARE, S.L., a corporation established under the laws of the Kingdom of Spain (the "Applicant"). The application was published for oppositions on August 19, 2024, and still open for oppositions.
The application was filed in Spanish (English was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations acting on the central nervous system
Central nervous system stimulants
Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases.